Jazz Pharmaceuticals (JAZZ) Stock Research, Analysis & News

Quick Analysis on Jazz Pharmaceuticals (JAZZ) Stock as of January 29, 2020

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Jazz Pharmaceuticals (JAZZ) Stock below)

Jazz Pharmaceuticals (JAZZ) Stock Profile Summary

Jazz Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes products for neurology and psychiatry primarily in the United States. The companys marketed products include Xyrem, a sodium oxybate oral solution for the treatment of excessive daytime sleepiness and cataplexy in patients with narcolepsy; and Luvox CR for obsessive compulsive disorder and social anxiety disorder. The companys late-stage product candidate comprises JZP-6, which has completed two Phase III pivotal clinical trials, for the treatment of fibromyalgia. Its other product candidates in clinical development consist of JZP-8, an intranasal formulation of clonazepam for the treatment of recurrent acute repetitive seizures in epilepsy patients who continue to have seizures while on stable anti-epileptic regimens; JZP-4, a controlled release formulation of an anticonvulsant for the treatment of epilepsy and bipolar disorder; and JZP-7, a transdermal gel formulation of ropinirole for the treatment of restless legs syndrome. In addition, the company is developing oral tablet forms for sodium oxybate. Jazz Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Palo Alto, California.

Jazz Pharmaceuticals (JAZZ) Stock Key Statistics Research and Analysis as of January 29, 2020

Jazz Pharmaceuticals (JAZZ) Stock Competitor Research and Analysis

Cephalon Inc. (CEPH)Eli Lilly & Co. (LLY)
Pfizer Inc. (PFE)Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)Novartis AG (NVS)
AstraZeneca PLC (AZN)Abbott Laboratories (ABT)

Mutual Funds with Jazz Pharmaceuticals (JAZZ) Stock in its top 10 holdings

FundCategoryJAZZ Holding Percentage
AlphaMark Large Cap GrowthLarge Growth3.82%
Dreyfus/The Boston Co Sm/Md Cp Gr AMid-Cap Growth1.85%
Fidelity Advisor Value AMid-Cap Value1.11%
Fidelity Advisor Mid Cap II AMid-Cap Growth1.02%
Fidelity Advisor Value TMid-Cap Value1.11%

ETFs with Jazz Pharmaceuticals (JAZZ) Stock in its top 10 holdings

Stock Research on Jazz Pharmaceuticals (JAZZ)

Latest Market News on Jazz Pharmaceuticals (JAZZ)

Click here to find the latest news on Jazz Pharmaceuticals (JAZZ)

Looking for Market Opportunties?

Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center

See other companies in the same industry

Cephalon Inc. (CEPH)
Eli Lilly & Co. (LLY)
Pfizer Inc. (PFE)
Amgen Inc. (AMGN)
Biogen Idec Inc. (BIIB)
Genzyme Corp. (GENZ)
Gilead Sciences Inc. (GILD)
Life Technologies Corporation (LIFE)
Teva Pharmaceutical Industries Limited (TEVA)
Watson Pharmaceuticals Inc. (WPI)
King Pharmaceuticals Inc. (KG)
Mylan, Inc. (MYL)
Johnson & Johnson (JNJ)
GlaxoSmithKline plc (GSK)
Sanofi-Aventis (SNY)
Novartis AG (NVS)
AstraZeneca PLC (AZN)
Abbott Laboratories (ABT)